|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|
| Cash Flows From Operating Activities: | |||
| Net income (loss) | |||
| Adjustments to reconcile net income (loss) to net cash used in operating activities: | |||
| Interest earned on cash held in trust account | |||
| Transaction costs associated with warrant liabilities | |||
| Change in fair value of derivative liabilities and forward purchase asset/liability | |||
| Change in fair value of derivative liabilities | |||
| Change in fair value of forward purchase liability | |||
| Changes in operating assets and liabilities: | |||
| Prepaid expenses | |||
| Accrued Offering Costs | |||
| Accounts payable and accrued expenses | |||
| Net Cash Used in Operating Activities | |||
| Cash Flows From Investing Activities: | |||
| Cash deposited into trust account | |||
| Cash withdrawn from trust account for redemptions | |||
| Due from Sponsor | |||
| Cash withdrawn from trust account to pay taxes | |||
| Net Cash Provided by (Used in) Investing Activities | |||
| Cash Flows From Financing Activities: | |||
| Sale of Units in Public Offering, net of underwriting discount | |||
| Sale of Private Placement Warrants to Sponsor | |||
| Proceeds from Sponsor note payable | |||
| Redemption of Class A stock | |||
| Repayment of Sponsor note payable | |||
| Net Cash Provided By (Used In) Financing Activities | |||
| Net change in cash and cash - restricted | |||
| Cash and Cash - Restricted at beginning of period | |||
| Cash and Cash - Restricted at end of period | |||
| Deferred underwriting costs | |||
| Deferred underwriting compensation charged to additional paid-in capital in connection with the Initial Public Offering | |||
| Supplemental Cash Disclosures: | |||
| Cash paid for income taxes | |||
| Cash | |||
| Cash - restricted |
Loading...
